National Asset Management, Inc. Invitae Corp Transaction History

National Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$14.7 - $28.67 $139,120 - $271,332	-9,464 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$24.31 - $33.6 $32,089 - $44,352	-1,320 Reduced 12.24%	9,464 $270,000
Q2 2021 Aug 10, 2021	SELL	$26.09 - $40.4 $18,028 - $27,916	-691 Reduced 6.02%	10,784 $364,000
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $379,363 - $653,271	11,475 New	11,475 $439,000
Q4 2018 Feb 08, 2019	SELL	$9.26 - $16.38 $114,824 - $203,112	-12,400 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$7.54 - $18.31 $93,496 - $227,043	12,400 New	12,400 $208,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.